Search Results - "Leming PD"

Immunotherapy and liver cancer research trends and the 100 most cited articles: A bibliometric analysis.

Authors: Kong, Yang Wang, Yizhi Yang, Qifan et al.

Source: Technology & Health Care. 2024, Vol. 32 Issue 6, p5141-5155. 15p.

Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer.

Authors: Wang, Yuqian Jiang, Cheng Zhou, Huiling et al.

Source: Experimental Hematology & Oncology. 9/29/2025, Vol. 14 Issue 1, p1-64. 64p.

Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.

Authors: Catalá-López, Ferrán Aleixandre-Benavent, Rafael Caulley, Lisa et al.

Source: Trials. 1/7/2020, Vol. 21 Issue 1, p1-24. 24p. 3 Diagrams, 8 Charts, 1 Graph.

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.

Authors: Pasello, Giulia Fabricio, Aline S. C. Del Bianco, Paola et al.

Source: Journal of Translational Medicine. 3/5/2024, Vol. 22 Issue 1, p1-16. 16p.

Immunoprevention of non-viral cancers: challenges and strategies for early intervention.

Authors: Biswas, Kajal Kuo, Lillian S. Shoemaker, Robert H. et al.

Source: Cancer Cell International. 5/28/2025, Vol. 25 Issue 1, p1-17. 17p.

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Authors: Grenda, Anna Iwan, Ewelina Chmielewska, Izabela et al.

Source: AMB Express. 7/6/2022, Vol. 12 Issue 1, p1-7. 7p.

Elevated levels of neutrophil related chemokine citrullinated histone H3, interleukin-8 and C-reaction protein in patients with immune checkpoint inhibitor therapy: predictive biomarkers for response to treatment.

Authors: Wang, Xueping Huang, Hao Zhang, Lin et al.

Source: Cancer Cell International. 8/14/2023, Vol. 23 Issue 1, p1-13. 13p.

Roles of DEPDC1 in various types of cancer (Review).

Authors: DANQI LIU HAIMA LI JIA OUYANG

Source: Oncology Letters. Nov2024, Vol. 28 Issue 5, p1-9. 9p.

Risk of confounding variables in multivariate analysis.

Authors: Gagnon, Bruno Hanna, Andrew M. R.

Source: Journal of Translational Medicine. 4/9/2022, Vol. 20 Issue 1, p1-2. 2p.

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms.

Authors: Blessin, Niclas C. Spriestersbach, Patrick Li, Wenchao et al.

Source: Cellular Oncology (2211-3428). Jun2020, Vol. 43 Issue 3, p421-430. 10p.

Prognostic value of liver metastasis in patients with esophageal squamous cell carcinoma treated with nivolumab.

Authors: Morita, Ryuichi Ishikawa, Takeshi Doi, Toshifumi et al.

Source: Oncology Letters. Mar2025, Vol. 29 Issue 3, pN.PAG-N.PAG. 1p.

PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer.

Authors: Boyero, Laura Martin-Padron, Joel Fárez-Vidal, María Esther et al.

Source: Cellular Oncology (2211-3428). Apr2022, Vol. 45 Issue 2, p323-332. 10p.

The CD112R/CD112 axis: a breakthrough in cancer immunotherapy.

Authors: Zeng, Taofei Cao, Yuqing Jin, Tianqiang et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 9/10/2021, Vol. 40 Issue 1, p1-11. 11p.

Analyses of repeated failures in cancer therapy for solid tumors: poor tumor‐selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors: Maeda, Hiroshi Khatami, Mahin

Source: Clinical & Translational Medicine. Dec2018, Vol. 7 Issue 1, p1-20. 20p.

Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition.

Authors: Garcia, Elizabeth Luna, Ismat Persad, Kaya L. et al.

Source: Scientific Reports. 6/3/2021, Vol. 11 Issue 1, p1-15. 15p.

VIGLA-M: visual gene expression data analytics.

Authors: Navas-Delgado, Ismael García-Nieto, José López-Camacho, Esteban et al.

Source: BMC Bioinformatics. 4/18/2019 Supplement4, Vol. 20 Issue 4, p1-11. 11p. 3 Diagrams, 2 Charts, 1 Graph.

Application and Benefits of Web-Mediated Symptom Reporting for Patients Undergoing Immunotherapy: A Clinical Example.

Authors: Denis, Fabrice Koontz, Bridget F. Letellier, Christophe

Source: Case Reports in Oncology. Sep-Dec2018, Vol. 11 Issue 3, p763-768. 6p.

In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction.

Authors: Lu, Chih-Hao Chung, Wei-Min Tsai, Chun-Hao et al.

Source: Scientific Reports. 10/22/2022, Vol. 12 Issue 1, p1-11. 11p.

Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy.

Authors: Jugniot, Natacha Dahl, Jeremy J. Paulmurugan, Ramasamy

Source: Journal of Experimental & Clinical Cancer Research (17569966). 10/12/2022, Vol. 41 Issue 1, p1-18. 18p.

Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2.

Authors: Jalal, Khurshid Khan, Kanwal Basharat, Zarrin et al.

Source: Environmental Science & Pollution Research. Aug2022, Vol. 29 Issue 40, p60035-60053. 19p.